Newest Issue is Out. Get your exclusive copy today.
TechnoTrends provide comprehensive coverage of the innovations and inventions in pharma products and pharma technologies across the world. The up-to-date listing of latest pharmaceutical product news and technology trends in the global pharma industry, keeps you abreast with all the latest pharmaceutical innovations happening world over.
LianBio, discovered novel Mavacamten for the treatment of patients with obstructive hypertrophic cardiomyopathy (oHCM). Mavacamten is a first-in-class, oral, allosteric modulator of cardiac myosin which is under investigation for the treatment of excessive cardiac contractility. It lowers the risk of cardiac muscle contractility by restricting...
Blue Note Therapeutics discovered first-of-its-kind prescription-only digital therapeutic BNT200 for the treatment of anxiety and depressive symptoms in adults patients with acute myeloid leukemia (AML) hospitalised for a regimen of high-intensity induction chemotherapy. BNT200 is a software as a medical device (SaMD) designed t0 treat anxiety and depressive...
BioCardia®, Inc discovered breakthrough CardiAMP® Cell Therapy System for the treatment of heart failure. CardiAMP Cell Therapy makes use of patients own bone marrow cells delivered to the heart in a minimally invasive, catheter-based procedure. It uses pre-procedural screening assay...
Pathogenomix Inc, discovered novel Patho-Seq assay. Patho-Seq uses Next Generation Sequencing for the rapid identifaction of bacteria presented in human sample through dangerous and life-threatening infections. Patho-Seq detects hundreds of clinically relevant bacteria collected from wide...
AbbVie developed Telisotuzumab Vedotin (Teliso-V) an investigational antibody-drug conjugate (ADC), to treat patients with non-small cell lung cancer (NSCLC). (Teliso-V) is used to treat patients with advanced/metastatic epidermal growth factor receptor (EGFR) wild type, nonsquamous non-small cell lung cancer (NSCLC) consisting...
Daiichi Sankyo discovered new patritumab deruxtecan to treat patients with metastatic or locally advanced EGFR-mutated non-small cell lung cancer (NSCLC). Patritumab deruxtecan (HER3-DXd), is the firt irst-in-class HER3 directed antibody drug conjugate (ADC), applicable with third-generation tyrosine kinase inhibitor...
Zetagen Therapeutics, discovered novel ZetaMet™ technology for the treatment of metastatic bone cancers. This technology is the first to suspend cancer inhibit pain, and regenerate bone. ZetaMet™ technology was earlier known as ZetaFuse. It is a synthetic, small-molecule, inductive biologic technology introduced to target and resolve metastatic...
RefleXion Medical, Inc discovered breakthrough biology-guided radiotherapy* (BgRT)for the treatment of lung cancer. Biology-guided radiotherapy(BgRT), the first and only technology has the ability to detect and treat the circulating tumours producing active emissions from each tumour....
Pear therapeutics developed new reSET-A™ PDT product candidate for the treatment of alcohol use disorder (AUD) PDTsare new therapeutic class designed with software to directly treat disease. Similar to traditional medicines, PDT’s are developed and tested...
Roche discovered breakthrough therapy Susvimo™ (ranibizumab injection) for the treatment of people with neovascular or ‘wet’ age-related macular degeneration (nAMD). Susvimoearlier known as port delivery system with ranibizumab is the first and only alternative treatment in 15 years which provides standard-of-care...
